Grants

In recognition of it's potential in detecting and treating cancer in addition to BPH Corporate's investment; HLS5 has attracted research funding from the NHMRC, Cancer Council of WA, the National Breast Cancer Foundation, the Medical Research Foundation of Royal Perth Hospital and the Scott Kirkbride Melanoma Research Centre.